data_2a5e_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2a5e _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.935 0 N-CA-C 109.979 -0.378 . . . . 18.879999999999999 109.979 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 54.8 tp10 -47.33 104.51 0.41 Allowed Pre-proline 0 N--CA 1.505 2.285 0 O-C-N 120.92 -1.113 . . . . 17.43 109.801 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.509 ' HA ' ' HB2' ' A' ' 7' ' ' SER . 65.9 Cg_endo -92.56 -162.93 0.1 Allowed 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.817 1.43 . . . . 16.800000000000001 112.147 -177.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.412 ' O ' ' CB ' ' A' ' 5' ' ' ALA . . . 71.41 44.05 0.57 Allowed 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 115.683 -0.69 . . . . 13.68 111.193 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' A' ' 4' ' ' ALA . . . 169.89 -54.9 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.202 0.525 . . . . 11.970000000000001 110.032 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -110.5 -12.17 17.73 Favored Glycine 0 N--CA 1.486 1.975 0 C-N-CA 119.88 -1.152 . . . . 10.18 110.25 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.509 ' HB2' ' HA ' ' A' ' 3' ' ' PRO . 9.6 t -72.37 -129.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.705 -1.468 . . . . 9.0600000000000005 108.451 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.505 ' HB2' ' O ' ' A' ' 7' ' ' SER . 3.5 m 61.61 -90.72 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.102 -0.998 . . . . 7.4199999999999999 111.919 178.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.474 ' C ' ' O ' ' A' ' 8' ' ' SER . 69.7 mtm 45.37 29.57 0.59 Allowed 'General case' 0 N--CA 1.506 2.359 0 N-CA-C 106.49 -1.67 . . . . 7.2699999999999996 106.49 -176.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.442 ' N ' ' C ' ' A' ' 8' ' ' SER 0.25 2.6 tt0 -84.37 117.22 68.19 Favored Pre-proline 0 C--N 1.304 -1.374 0 CA-C-N 114.387 -1.279 . . . . 6.5099999999999998 112.845 -175.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.952 ' O ' ' N ' ' A' ' 13' ' ' ALA . 52.1 Cg_endo -76.97 68.29 7.33 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 N-CA-C 104.273 -3.01 . . . . 6.2199999999999998 104.273 174.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -34.64 11.48 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.566 0 N-CA-C 114.287 1.217 . . . . 4.8399999999999999 114.287 -176.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.952 ' N ' ' O ' ' A' ' 11' ' ' PRO . . . -68.68 -32.24 71.92 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.724 -1.235 . . . . 1.78 109.322 178.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.537 ' O ' ' OG1' ' A' ' 18' ' ' THR . 0.7 OUTLIER -45.71 -37.82 6.25 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.34 -0.85 . . . . 2.4700000000000002 109.623 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.487 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 35.4 m0 -62.26 -54.76 36.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.784 -0.572 . . . . 2.4700000000000002 109.997 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 13' ' ' ALA . 1.1 pp -51.12 -25.55 5.33 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.021 -1.049 . . . . 2.3100000000000001 109.02 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.449 ' N ' ' HG ' ' A' ' 16' ' ' LEU . . . -87.48 -54.19 4.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.5 -0.75 . . . . 1.29 109.318 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.537 ' OG1' ' O ' ' A' ' 14' ' ' ASP . 0.2 OUTLIER -57.99 -48.05 81.17 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.208 -0.933 . . . . 1.6100000000000001 109.092 178.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.407 ' CB ' HG21 ' A' ' 28' ' ' VAL . . . -57.51 -43.02 83.92 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.825 -0.806 . . . . 1.1000000000000001 108.825 178.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.484 ' HB3' ' CB ' ' A' ' 52' ' ' MET . . . -61.41 -49.08 78.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.527 -0.733 . . . . 1.0800000000000001 109.075 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 51' ' ' VAL . . . -57.57 -30.21 65.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.524 -0.735 . . . . 1.1200000000000001 109.81 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.4 mtt180 -89.99 18.05 6.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.616 -0.678 . . . . 3.3700000000000001 110.267 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 56.54 41.1 88.53 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.562 -1.415 . . . . 0.68999999999999995 109.562 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.37 86.6 2.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.5 -1.0 . . . . 3.6699999999999999 109.958 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.416 ' O ' ' HB2' ' A' ' 29' ' ' ARG . 81.4 t -68.51 -52.68 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.376 -0.827 . . . . 1.3100000000000001 110.131 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -50.45 -45.24 55.91 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.441 -0.787 . . . . 2.04 110.94 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.91 -53.3 59.92 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.307 -0.871 . . . . 1.95 110.321 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.421 HG11 ' CD2' ' A' ' 62' ' ' LEU . 46.3 t -65.88 -44.27 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.415 -0.803 . . . . 1.25 110.338 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.58 ' HA ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -47.5 -49.56 25.54 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.499 -0.751 . . . . 2.5600000000000001 110.509 -179.744 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.36 -39.54 39.02 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.502 -0.749 . . . . 1.1699999999999999 110.458 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.4 mt -54.82 -66.81 0.34 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.29 -0.881 . . . . 1.5800000000000001 110.3 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.776 HD21 ' CG ' ' A' ' 66' ' ' HIS . 0.2 OUTLIER -53.07 -39.41 63.28 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.438 -0.789 . . . . 2.0099999999999998 110.587 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 29' ' ' ARG . 1.7 mt-10 -68.9 -13.25 62.32 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.054 -1.029 . . . . 1.6499999999999999 109.522 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -98.82 -16.71 18.78 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.317 -0.865 . . . . 1.3799999999999999 110.729 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 141.58 8.13 0.72 Allowed Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.512 -1.328 . . . . 0.93000000000000005 111.748 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.754 ' HB2' ' HG ' ' A' ' 32' ' ' LEU . . . -57.92 129.57 42.54 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.6 -1.53 . . . . 1.3200000000000001 109.983 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.442 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 3.2 tp -64.14 132.21 95.23 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.39 -0.819 . . . . 2.2799999999999998 110.48 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.22 -37.16 3.55 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.536 1.282 . . . . 1.3700000000000001 110.498 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -117.86 70.78 0.8 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.321 -0.862 . . . . 1.49 110.356 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.581 ' CB ' ' HB2' ' A' ' 13' ' ' ALA . . . -101.9 140.09 20.89 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.36 -0.837 . . . . 1.1599999999999999 110.591 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -76.39 121.08 5.87 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.726 1.382 . . . . 1.97 110.468 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -97.03 177.42 5.61 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.291 -0.88 . . . . 2.9399999999999999 110.02 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.3 m -86.09 -5.05 59.28 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.249 -0.907 . . . . 2.5299999999999998 110.695 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -98.44 9.54 42.91 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.159 -0.963 . . . . 2.75 110.607 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.59 22.52 32.46 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.298 -1.521 . . . . 0.72999999999999998 109.298 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.6 mtt180 -115.04 153.68 30.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.442 -1.034 . . . . 2.5800000000000001 110.266 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.616 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 4.2 mmp_? -68.07 172.69 3.92 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.432 -0.793 . . . . 2.71 109.594 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.768 ' HB2' HD23 ' A' ' 63' ' ' LEU . 46.2 Cg_endo -72.29 -11.47 26.81 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 O-C-N 123.466 1.245 . . . . 1.6399999999999999 111.868 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.473 ' O ' ' HG2' ' A' ' 52' ' ' MET . 7.8 mt -109.02 -37.67 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.892 -1.13 . . . . 1.47 109.371 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -53.18 -21.78 5.6 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.139 -0.976 . . . . 1.8 109.412 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.456 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 11.9 p -113.18 39.66 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.476 -0.765 . . . . 1.1699999999999999 109.844 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.484 ' CB ' ' HB3' ' A' ' 20' ' ' ALA . 0.2 OUTLIER -103.4 33.78 3.2 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.99 -1.069 . . . . 1.3999999999999999 110.191 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.437 ' CB ' ' O ' ' A' ' 52' ' ' MET . 4.8 tmm? 69.07 -17.71 0.2 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.63 -0.669 . . . . 1.5 111.35 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.468 ' H ' ' C ' ' A' ' 52' ' ' MET . 0.0 OUTLIER 52.31 24.23 2.79 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.918 -1.113 . . . . 1.0800000000000001 110.17 -179.624 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.421 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -120.42 9.08 10.97 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.281 -1.528 . . . . 0.62 109.281 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -153.16 93.31 1.71 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.349 -1.089 . . . . 1.05 109.921 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.35 -25.73 50.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.364 -0.835 . . . . 1.1000000000000001 109.86 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 35.3 mtt180 -54.2 -43.66 70.95 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.374 -0.829 . . . . 2.9700000000000002 109.638 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.422 HG12 ' CB ' ' A' ' 20' ' ' ALA . 61.1 t -56.11 -53.4 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.365 -0.835 . . . . 1.24 108.976 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -53.91 -40.28 66.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.424 -0.797 . . . . 1.24 109.828 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.401 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -52.83 -68.81 0.14 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.092 -1.005 . . . . 2.02 110.068 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.711 HD22 ' CD1' ' A' ' 32' ' ' LEU . 0.7 OUTLIER -47.35 -58.73 3.81 Favored 'General case' 0 C--N 1.313 -0.978 0 O-C-N 121.282 -0.886 . . . . 2.1499999999999999 109.778 178.837 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.768 HD23 ' HB2' ' A' ' 48' ' ' PRO . 2.3 mt -53.47 -65.76 0.51 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.675 -0.64 . . . . 1.6699999999999999 110.713 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 60' ' ' ALA . 2.8 tt -48.58 -54.79 13.15 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.612 -0.68 . . . . 2.0899999999999999 110.634 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.417 ' CD2' ' HA ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -59.5 -24.26 63.48 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.236 -0.915 . . . . 1.75 109.887 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.776 ' CG ' HD21 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -87.11 -27.83 22.86 Favored 'General case' 0 C--N 1.31 -1.142 0 O-C-N 121.273 -0.892 . . . . 2.1699999999999999 110.122 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 132.6 36.65 0.28 Allowed Glycine 0 N--CA 1.481 1.685 0 C-N-CA 119.925 -1.131 . . . . 0.84999999999999998 111.11 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.458 ' HB3' HG13 ' A' ' 49' ' ' ILE . . . -63.62 -161.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.744 -1.445 . . . . 1.0700000000000001 109.555 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.472 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -120.32 62.7 9.16 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.229 -0.92 . . . . 2.73 109.825 179.616 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.2 -14.39 37.76 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.825 1.434 . . . . 0.65000000000000002 110.411 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.403 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 20.9 t30 -104.81 -63.15 1.25 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.362 -0.836 . . . . 2.3100000000000001 110.397 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -49.49 152.17 1.41 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.367 -0.833 . . . . 1.04 110.828 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -136.37 -163.38 1.4 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.434 -0.791 . . . . 1.21 109.883 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.41 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -92.1 133.7 29.85 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.242 -0.911 . . . . 1.5800000000000001 109.679 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.63 -7.44 21.2 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.33 1.174 . . . . 0.87 110.708 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.62 -56.87 3.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.156 -0.965 . . . . 1.52 109.861 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.57 ' CG2' ' CZ3' ' A' ' 110' ' ' TRP . 19.0 p -120.23 15.71 12.28 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.301 -0.874 . . . . 1.7 110.28 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.461 ' HB3' ' O ' ' A' ' 107' ' ' ARG . 4.2 mt 49.32 28.64 2.38 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.362 -0.836 . . . . 1.2 110.995 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 m -65.13 102.37 0.63 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 1.3999999999999999 110.676 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.567 ' CG ' ' HD2' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -79.77 157.59 74.09 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.254 -0.904 . . . . 2.2999999999999998 108.756 178.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.567 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 39.2 Cg_endo -66.03 -12.86 37.23 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.219 1.115 . . . . 0.51000000000000001 110.325 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.5 t -63.91 -34.19 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.354 -0.841 . . . . 1.1499999999999999 109.692 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.427 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 14.9 m80 -69.11 -47.03 66.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.391 -0.818 . . . . 0.35999999999999999 109.321 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.461 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 1.0 OUTLIER -48.27 -43.85 33.07 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.902 -0.498 . . . . 1.4299999999999999 111.256 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.424 ' HB3' HD11 ' A' ' 94' ' ' LEU . . . -62.33 -61.0 2.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.084 -1.01 . . . . 1.0600000000000001 109.499 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.496 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . -60.21 -32.98 71.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.379 -0.825 . . . . 1.04 110.845 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.427 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -52.9 -44.16 66.72 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.014 -1.054 . . . . 3.4399999999999999 110.415 -179.727 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.405 ' HB2' ' HB3' ' A' ' 54' ' ' MET . 0.4 OUTLIER -91.5 -5.02 54.86 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.37 -0.831 . . . . 2.0099999999999998 110.204 179.764 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.61 33.77 26.96 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.43 -1.468 . . . . 0.44 109.43 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.421 ' CE2' ' C ' ' A' ' 55' ' ' GLY . 0.3 OUTLIER -102.69 99.43 9.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.264 -1.139 . . . . 1.0600000000000001 110.949 -179.558 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.43 ' HA ' HD12 ' A' ' 94' ' ' LEU . 0.4 OUTLIER -75.57 -34.59 60.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.914 . . . . 1.8799999999999999 109.841 179.348 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -51.09 -38.94 54.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.437 -0.79 . . . . 1.71 109.941 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 52.9 m -66.67 -43.45 84.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.553 -0.717 . . . . 1.0700000000000001 109.559 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 91' ' ' LEU . 1.8 mp -55.62 -43.12 75.82 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.427 -0.796 . . . . 1.74 109.789 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 99' ' ' ARG . 60.0 t -57.36 -53.07 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.489 -0.757 . . . . 1.24 109.809 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 52.2 t -53.33 -45.79 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.32 -0.862 . . . . 1.1499999999999999 110.018 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.43 ' HA ' ' CD1' ' A' ' 64' ' ' LEU . 0.3 OUTLIER -56.62 -53.29 59.31 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.451 -0.781 . . . . 1.77 110.531 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -80.09 -12.44 59.68 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.292 -0.88 . . . . 1.1399999999999999 110.779 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' A' ' 95' ' ' VAL . 14.2 ttt85 -79.13 -16.91 55.98 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.232 -0.918 . . . . 3.4300000000000002 110.756 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.425 ' CB ' ' CD2' ' A' ' 64' ' ' LEU . . . -127.49 -39.9 1.82 Allowed 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.545 -0.862 . . . . 1.5900000000000001 110.439 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 161.3 107.8 0.22 Allowed Glycine 0 N--CA 1.483 1.823 0 N-CA-C 109.614 -1.395 . . . . 1.4399999999999999 109.614 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -163.86 115.46 1.37 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.24 -1.153 . . . . 1.24 110.816 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 11.1 ttt180 -70.35 117.49 11.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.341 -0.849 . . . . 2.7000000000000002 109.417 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.559 ' CB ' ' HA ' ' A' ' 134' ' ' ALA . 1.0 OUTLIER -105.49 9.56 33.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.336 -0.852 . . . . 1.7 110.908 -179.495 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -111.97 50.71 0.83 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.962 -1.086 . . . . 1.8899999999999999 110.431 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.428 ' CG1' ' CD ' ' A' ' 80' ' ' ARG . 1.2 p -108.39 -169.12 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.29 -0.881 . . . . 1.1799999999999999 109.865 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.461 ' O ' ' HB3' ' A' ' 78' ' ' LEU . 44.7 mtm180 -136.78 155.39 49.89 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.536 -0.728 . . . . 3.2799999999999998 109.133 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.4 OUTLIER -86.12 50.56 2.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.12 -0.987 . . . . 1.6699999999999999 109.881 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.47 ' HB1' ' O ' ' A' ' 108' ' ' ASP . . . 62.07 -60.84 0.11 Allowed 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 122.045 0.926 . . . . 1.2 110.663 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.591 ' N ' ' O ' ' A' ' 108' ' ' ASP . 2.1 m-90 -59.65 -34.93 73.45 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.706 -0.679 . . . . 3.29 110.78 -178.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 133.21 -5.3 4.97 Favored Glycine 0 N--CA 1.484 1.881 0 C-N-CA 119.96 -1.114 . . . . 2.1800000000000002 110.929 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -79.19 158.31 27.69 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.964 -1.315 . . . . 4.0999999999999996 111.005 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.31 165.14 14.4 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.467 -0.771 . . . . 2.0099999999999998 110.131 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -68.5 -28.78 31.74 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.699 1.368 . . . . 0.46000000000000002 109.246 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.431 ' HA ' HD11 ' A' ' 130' ' ' LEU . 10.7 p -79.25 -31.66 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.489 -0.757 . . . . 1.2 109.31 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.93 -34.07 75.89 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.367 -0.833 . . . . 1.97 109.907 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.23 -45.49 69.69 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.425 -0.797 . . . . 1.97 110.403 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.403 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . . . -57.96 -47.4 83.05 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.372 -0.83 . . . . 1.27 110.686 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -60.4 -30.05 69.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.343 -0.848 . . . . 2.3399999999999999 110.56 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -79.77 -38.89 32.14 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.253 -0.905 . . . . 2.4399999999999999 110.9 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.407 ' HB3' ' NE2' ' A' ' 123' ' ' HIS . 0.8 OUTLIER -80.34 -29.39 38.01 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.146 -0.971 . . . . 1.95 110.426 -179.655 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 114.73 23.66 4.6 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 119.881 -1.152 . . . . 0.95999999999999996 110.543 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.496 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 81.4 m-70 -96.06 56.66 1.69 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.047 -1.266 . . . . 1.3600000000000001 109.038 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.437 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 23.3 mtp180 -46.96 -51.15 17.7 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.762 -0.586 . . . . 3.9399999999999999 110.451 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.426 ' HB3' HD13 ' A' ' 91' ' ' LEU . 50.1 m-20 -48.75 -39.68 25.8 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.553 -0.717 . . . . 1.9099999999999999 110.275 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.468 HG12 ' HA ' ' A' ' 86' ' ' ALA . 5.9 t -85.36 -41.11 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.291 -0.881 . . . . 1.1799999999999999 109.817 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.41 -35.99 77.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.199 -0.938 . . . . 1.1399999999999999 109.283 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 124' ' ' ARG . 10.0 ttt180 -66.45 -60.12 3.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.555 -0.716 . . . . 4.7800000000000002 109.363 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -57.96 -32.11 67.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.498 -0.751 . . . . 1.5600000000000001 109.663 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.431 HD11 ' HA ' ' A' ' 115' ' ' VAL . 17.6 mt -65.99 -48.53 70.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.436 -0.79 . . . . 1.8999999999999999 109.487 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -18.27 42.78 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.27 -0.893 . . . . 3.96 110.104 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -86.49 -57.96 2.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.183 -0.948 . . . . 1.23 109.788 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -88.41 -52.08 5.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.512 -0.743 . . . . 1.4099999999999999 110.02 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.559 ' HA ' ' CB ' ' A' ' 104' ' ' LEU . . . -62.48 -64.05 1.04 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.488 -0.757 . . . . 1.3500000000000001 110.394 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 137' ' ' THR . . . -106.59 53.57 0.62 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.451 -1.459 . . . . 2.2999999999999998 109.451 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -53.18 90.39 0.01 OUTLIER Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.568 -1.413 . . . . 3.6899999999999999 109.568 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.812 ' HB ' ' HA ' ' A' ' 147' ' ' ALA . 22.0 p -150.24 -179.75 7.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.48 -1.012 . . . . 3.8599999999999999 110.39 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 11.0 mtt85 -135.8 -103.17 0.21 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.238 -0.914 . . . . 9.8900000000000006 110.165 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 146' ' ' ASP . . . -168.34 -153.86 8.47 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.42 -1.472 . . . . 6.3700000000000001 109.42 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 7.8 t 41.93 -140.37 0.13 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.525 -0.985 . . . . 7.8899999999999997 112.064 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -137.84 160.01 40.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.331 -0.855 . . . . 10.1 110.967 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.682 ' O ' ' CB ' ' A' ' 143' ' ' ALA . 0.1 OUTLIER 58.46 153.32 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.567 -0.708 . . . . 9.8900000000000006 112.538 178.45 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.682 ' CB ' ' O ' ' A' ' 142' ' ' HIS . . . 124.87 -121.18 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.077 0 N-CA-C 107.282 -1.377 . . . . 8.7599999999999998 107.282 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.633 ' O ' ' CB ' ' A' ' 145' ' ' ILE . 0.0 OUTLIER -84.82 10.53 11.28 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.463 -1.398 . . . . 8.5299999999999994 107.479 176.457 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.714 ' CD1' ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER 123.52 -13.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 C-N-CA 125.691 1.596 . . . . 12.220000000000001 107.405 -178.431 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.758 ' OD2' ' HB2' ' A' ' 152' ' ' SER . 0.0 OUTLIER 78.92 -35.82 0.17 Allowed 'General case' 0 N--CA 1.503 2.176 0 CA-C-N 114.475 -1.238 . . . . 12.800000000000001 113.554 177.873 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.812 ' HA ' ' HB ' ' A' ' 137' ' ' THR . . . -177.02 161.32 1.9 Allowed 'General case' 0 C--N 1.278 -2.519 0 O-C-N 121.238 -0.914 . . . . 14.640000000000001 113.036 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.619 ' O ' ' C ' ' A' ' 149' ' ' GLU . . . -8.85 76.73 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.512 0 N-CA-C 113.312 0.856 . . . . 16.760000000000002 113.312 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.714 ' HA ' ' CD1' ' A' ' 145' ' ' ILE . 35.8 mt-10 1.97 76.36 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.644 0 CA-C-O 121.321 0.582 . . . . 18.140000000000001 112.289 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.546 ' O ' ' O ' ' A' ' 154' ' ' ILE . . . -167.76 -68.11 0.03 OUTLIER Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.934 -1.127 . . . . 19.420000000000002 110.3 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.688 ' O ' ' OD2' ' A' ' 146' ' ' ASP . 55.7 Cg_endo -75.73 99.12 1.24 Allowed 'Trans proline' 0 C--N 1.296 -2.205 0 O-C-N 123.861 1.453 . . . . 21.649999999999999 110.961 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.758 ' HB2' ' OD2' ' A' ' 146' ' ' ASP . 14.1 t 171.71 -158.8 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.524 0 O-C-N 121.202 -0.936 . . . . 22.649999999999999 110.058 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.559 ' N ' ' OG ' ' A' ' 152' ' ' SER . 23.0 t0 -76.87 13.13 1.11 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 106.673 -1.603 . . . . 24.100000000000001 106.673 175.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.635 ' H ' ' C ' ' A' ' 152' ' ' SER . 0.3 OUTLIER -126.32 117.83 23.32 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 106.849 -1.538 . . . . 26.530000000000001 106.849 179.06 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.519 ' O ' ' HB3' ' A' ' 156' ' ' ASP . 53.0 Cg_endo -79.98 10.79 3.02 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 O-C-N 123.299 1.157 . . . . 28.57 113.578 -177.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.519 ' HB3' ' O ' ' A' ' 155' ' ' PRO . 1.2 p30 . . . . . 0 N--CA 1.509 2.482 0 CA-C-O 118.095 -0.955 . . . . 30.710000000000001 110.183 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.935 0 N-CA-C 109.979 -0.378 . . . . 18.489999999999998 109.979 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 54.8 tp10 -47.33 104.51 0.41 Allowed Pre-proline 0 N--CA 1.505 2.285 0 O-C-N 120.92 -1.113 . . . . 17.02 109.801 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.599 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 65.9 Cg_endo -92.56 -162.93 0.1 Allowed 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.817 1.43 . . . . 16.02 112.147 -177.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.62 ' O ' ' HB2' ' A' ' 5' ' ' ALA . . . 71.41 44.05 0.57 Allowed 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 115.683 -0.69 . . . . 13.31 111.193 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.62 ' HB2' ' O ' ' A' ' 4' ' ' ALA . . . 169.89 -54.9 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.202 0.525 . . . . 11.699999999999999 110.032 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -110.5 -12.17 17.73 Favored Glycine 0 N--CA 1.486 1.975 0 C-N-CA 119.88 -1.152 . . . . 10.07 110.25 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.518 ' O ' ' HB2' ' A' ' 8' ' ' SER . 9.6 t -72.37 -129.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.705 -1.468 . . . . 8.75 108.451 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.518 ' HB2' ' O ' ' A' ' 7' ' ' SER . 3.5 m 61.61 -90.72 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.102 -0.998 . . . . 7.2400000000000002 111.919 178.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.474 ' C ' ' O ' ' A' ' 8' ' ' SER . 69.7 mtm 45.37 29.57 0.59 Allowed 'General case' 0 N--CA 1.506 2.359 0 N-CA-C 106.49 -1.67 . . . . 6.96 106.49 -176.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.442 ' N ' ' C ' ' A' ' 8' ' ' SER 0.25 2.6 tt0 -84.37 117.22 68.19 Favored Pre-proline 0 C--N 1.304 -1.374 0 CA-C-N 114.387 -1.279 . . . . 6.5099999999999998 112.845 -175.91 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.952 ' O ' ' N ' ' A' ' 13' ' ' ALA . 52.1 Cg_endo -76.97 68.29 7.33 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 N-CA-C 104.273 -3.01 . . . . 5.3700000000000001 104.273 174.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -34.64 11.48 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.566 0 N-CA-C 114.287 1.217 . . . . 4.3700000000000001 114.287 -176.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.952 ' N ' ' O ' ' A' ' 11' ' ' PRO . . . -68.68 -32.24 71.92 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.724 -1.235 . . . . 1.4399999999999999 109.322 178.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.537 ' O ' ' OG1' ' A' ' 18' ' ' THR . 0.7 OUTLIER -45.71 -37.82 6.25 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.34 -0.85 . . . . 2.4700000000000002 109.623 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.702 ' HE3' HD21 ' A' ' 31' ' ' LEU . 35.4 m0 -62.26 -54.76 36.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.784 -0.572 . . . . 2.0600000000000001 109.997 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.932 ' CD1' HD21 ' A' ' 63' ' ' LEU . 1.1 pp -51.12 -25.55 5.33 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.021 -1.049 . . . . 1.73 109.02 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.46 ' N ' ' HG ' ' A' ' 16' ' ' LEU . . . -87.48 -54.19 4.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.5 -0.75 . . . . 0.62 109.318 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.537 ' OG1' ' O ' ' A' ' 14' ' ' ASP . 0.2 OUTLIER -57.99 -48.05 81.17 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.208 -0.933 . . . . 1.01 109.092 178.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.525 ' HB1' ' HB3' ' A' ' 27' ' ' GLU . . . -57.51 -43.02 83.92 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.825 -0.806 . . . . 0.39000000000000001 108.825 178.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.51 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -61.41 -49.08 78.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.527 -0.733 . . . . 0.31 109.075 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.724 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -57.57 -30.21 65.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.524 -0.735 . . . . 0.34000000000000002 109.81 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.4 mtt180 -89.99 18.05 6.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.616 -0.678 . . . . 2.8300000000000001 110.267 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 56.54 41.1 88.53 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.562 -1.415 . . . . 0.68999999999999995 109.562 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.37 86.6 2.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.5 -1.0 . . . . 2.96 109.958 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.606 HG22 HG23 ' A' ' 59' ' ' VAL . 81.4 t -68.51 -52.68 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.376 -0.827 . . . . 0.57999999999999996 110.131 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -50.45 -45.24 55.91 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.441 -0.787 . . . . 2.04 110.94 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.525 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -58.91 -53.3 59.92 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.307 -0.871 . . . . 1.95 110.321 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.639 HG12 ' CD2' ' A' ' 62' ' ' LEU . 46.3 t -65.88 -44.27 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.415 -0.803 . . . . 0.58999999999999997 110.338 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.908 ' HA ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -47.5 -49.56 25.54 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.499 -0.751 . . . . 2.0299999999999998 110.509 -179.744 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.36 -39.54 39.02 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.502 -0.749 . . . . 0.53000000000000003 110.458 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.702 HD21 ' HE3' ' A' ' 15' ' ' TRP . 5.4 mt -54.82 -66.81 0.34 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.29 -0.881 . . . . 1.01 110.3 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.943 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 0.2 OUTLIER -53.07 -39.41 63.28 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.438 -0.789 . . . . 1.4299999999999999 110.587 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 29' ' ' ARG . 1.7 mt-10 -68.9 -13.25 62.32 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.054 -1.029 . . . . 1.6499999999999999 109.522 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -98.82 -16.71 18.78 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.317 -0.865 . . . . 0.95999999999999996 110.729 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 141.58 8.13 0.72 Allowed Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.512 -1.328 . . . . 0.73999999999999999 111.748 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.943 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -57.92 129.57 42.54 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.6 -1.53 . . . . 0.72999999999999998 109.983 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.696 ' CB ' ' HB2' ' A' ' 13' ' ' ALA . 3.2 tp -64.14 132.21 95.23 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.39 -0.819 . . . . 1.6299999999999999 110.48 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.22 -37.16 3.55 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.536 1.282 . . . . 1.0900000000000001 110.498 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -117.86 70.78 0.8 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.321 -0.862 . . . . 1.49 110.356 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.67 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -101.9 140.09 20.89 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.36 -0.837 . . . . 0.79000000000000004 110.591 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -76.39 121.08 5.87 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.726 1.382 . . . . 1.6299999999999999 110.468 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -97.03 177.42 5.61 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.291 -0.88 . . . . 2.52 110.02 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.3 m -86.09 -5.05 59.28 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.249 -0.907 . . . . 2.1200000000000001 110.695 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -98.44 9.54 42.91 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.159 -0.963 . . . . 2.4300000000000002 110.607 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.59 22.52 32.46 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.298 -1.521 . . . . 0.68999999999999995 109.298 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.6 mtt180 -115.04 153.68 30.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.442 -1.034 . . . . 2.1299999999999999 110.266 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.628 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 4.2 mmp_? -68.07 172.69 3.92 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.432 -0.793 . . . . 2.29 109.594 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.628 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 46.2 Cg_endo -72.29 -11.47 26.81 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 O-C-N 123.466 1.245 . . . . 1.6399999999999999 111.868 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.496 ' O ' ' HG2' ' A' ' 52' ' ' MET . 7.8 mt -109.02 -37.67 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.892 -1.13 . . . . 0.66000000000000003 109.371 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.46 ' NE2' ' O ' ' A' ' 79' ' ' THR . 20.3 tt0 -53.18 -21.78 5.6 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.139 -0.976 . . . . 1.8 109.412 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.724 HG22 ' HB2' ' A' ' 21' ' ' ALA . 11.9 p -113.18 39.66 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.476 -0.765 . . . . 0.67000000000000004 109.844 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.584 ' HE1' ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -103.4 33.78 3.2 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.99 -1.069 . . . . 1.3999999999999999 110.191 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.437 ' CB ' ' O ' ' A' ' 52' ' ' MET . 4.8 tmm? 69.07 -17.71 0.2 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.63 -0.669 . . . . 1.5 111.35 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.474 ' SD ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 52.31 24.23 2.79 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.918 -1.113 . . . . 1.0 110.17 -179.624 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.421 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -120.42 9.08 10.97 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.281 -1.528 . . . . 0.54000000000000004 109.281 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -153.16 93.31 1.71 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.349 -1.089 . . . . 0.65000000000000002 109.921 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.35 -25.73 50.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.364 -0.835 . . . . 0.39000000000000001 109.86 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 35.3 mtt180 -54.2 -43.66 70.95 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.374 -0.829 . . . . 2.46 109.638 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.606 HG23 HG22 ' A' ' 25' ' ' VAL . 61.1 t -56.11 -53.4 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.365 -0.835 . . . . 0.54000000000000004 108.976 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.584 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -53.91 -40.28 66.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.424 -0.797 . . . . 0.53000000000000003 109.828 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.83 -68.81 0.14 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.092 -1.005 . . . . 2.02 110.068 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.934 HD21 ' HB2' ' A' ' 32' ' ' LEU . 0.7 OUTLIER -47.35 -58.73 3.81 Favored 'General case' 0 C--N 1.313 -0.978 0 O-C-N 121.282 -0.886 . . . . 1.6000000000000001 109.778 178.837 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.932 HD21 ' CD1' ' A' ' 16' ' ' LEU . 2.3 mt -53.47 -65.76 0.51 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.675 -0.64 . . . . 1.1000000000000001 110.713 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.956 HD13 HG12 ' A' ' 96' ' ' VAL . 2.8 tt -48.58 -54.79 13.15 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.612 -0.68 . . . . 1.49 110.634 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.671 ' O ' HD12 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -59.5 -24.26 63.48 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.236 -0.915 . . . . 1.1399999999999999 109.887 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.778 ' CG ' HD22 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -87.11 -27.83 22.86 Favored 'General case' 0 C--N 1.31 -1.142 0 O-C-N 121.273 -0.892 . . . . 1.27 110.122 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 132.6 36.65 0.28 Allowed Glycine 0 N--CA 1.481 1.685 0 C-N-CA 119.925 -1.131 . . . . 0.67000000000000004 111.11 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.477 ' HB1' HG13 ' A' ' 49' ' ' ILE . . . -63.62 -161.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.744 -1.445 . . . . 0.52000000000000002 109.555 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.516 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -120.32 62.7 9.16 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.229 -0.92 . . . . 2.73 109.825 179.616 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.473 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 43.6 Cg_endo -69.2 -14.39 37.76 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.825 1.434 . . . . 0.65000000000000002 110.411 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.403 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 20.9 t30 -104.81 -63.15 1.25 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.362 -0.836 . . . . 1.95 110.397 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -49.49 152.17 1.41 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.367 -0.833 . . . . 0.94999999999999996 110.828 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -136.37 -163.38 1.4 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.434 -0.791 . . . . 0.56999999999999995 109.883 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.405 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -92.1 133.7 29.85 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.242 -0.911 . . . . 1.5800000000000001 109.679 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.63 -7.44 21.2 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.33 1.174 . . . . 0.80000000000000004 110.708 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.62 -56.87 3.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.156 -0.965 . . . . 0.97999999999999998 109.861 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . 1.102 HG22 ' CZ3' ' A' ' 110' ' ' TRP . 19.0 p -120.23 15.71 12.28 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.301 -0.874 . . . . 1.1699999999999999 110.28 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.483 ' HB3' ' O ' ' A' ' 107' ' ' ARG . 4.2 mt 49.32 28.64 2.38 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.362 -0.836 . . . . 0.56000000000000005 110.995 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.46 ' O ' ' NE2' ' A' ' 50' ' ' GLN . 5.2 m -65.13 102.37 0.63 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 0.75 110.676 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.771 ' HB2' HG11 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -79.77 157.59 74.09 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.254 -0.904 . . . . 1.78 108.756 178.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.584 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 39.2 Cg_endo -66.03 -12.86 37.23 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.219 1.115 . . . . 0.45000000000000001 110.325 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.816 HG13 HD23 ' A' ' 104' ' ' LEU . 78.5 t -63.91 -34.19 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.354 -0.841 . . . . 0.37 109.692 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.423 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 14.9 m80 -69.11 -47.03 66.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.391 -0.818 . . . . 0.31 109.321 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.474 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 1.0 OUTLIER -48.27 -43.85 33.07 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.902 -0.498 . . . . 1.4299999999999999 111.256 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.742 ' HB1' HD12 ' A' ' 94' ' ' LEU . . . -62.33 -61.0 2.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.084 -1.01 . . . . 0.27000000000000002 109.499 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.808 ' HB2' HD11 ' A' ' 130' ' ' LEU . . . -60.21 -32.98 71.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.379 -0.825 . . . . 0.40000000000000002 110.845 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.438 ' HG2' HD22 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -52.9 -44.16 66.72 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.014 -1.054 . . . . 2.77 110.415 -179.727 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.442 ' HB2' ' HB3' ' A' ' 54' ' ' MET . 0.4 OUTLIER -91.5 -5.02 54.86 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.37 -0.831 . . . . 2.0099999999999998 110.204 179.764 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.61 33.77 26.96 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.43 -1.468 . . . . 0.44 109.43 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.421 ' CE2' ' C ' ' A' ' 55' ' ' GLY . 0.3 OUTLIER -102.69 99.43 9.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.264 -1.139 . . . . 0.75 110.949 -179.558 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.505 HD12 ' HB3' ' A' ' 125' ' ' ASP . 0.4 OUTLIER -75.57 -34.59 60.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.914 . . . . 1.1799999999999999 109.841 179.348 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -51.09 -38.94 54.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.437 -0.79 . . . . 1.71 109.941 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.578 ' O ' HD12 ' A' ' 97' ' ' LEU . 52.9 m -66.67 -43.45 84.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.553 -0.717 . . . . 0.44 109.559 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.742 HD12 ' HB1' ' A' ' 85' ' ' ALA . 1.8 mp -55.62 -43.12 75.82 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.427 -0.796 . . . . 1.03 109.789 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 99' ' ' ARG . 60.0 t -57.36 -53.07 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.489 -0.757 . . . . 0.51000000000000001 109.809 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.956 HG12 HD13 ' A' ' 64' ' ' LEU . 52.2 t -53.33 -45.79 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.32 -0.862 . . . . 0.39000000000000001 110.018 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.795 ' HA ' HD11 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -56.62 -53.29 59.31 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.451 -0.781 . . . . 1.1399999999999999 110.531 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -80.09 -12.44 59.68 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.292 -0.88 . . . . 0.78000000000000003 110.779 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' A' ' 95' ' ' VAL . 14.2 ttt85 -79.13 -16.91 55.98 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.232 -0.918 . . . . 2.7999999999999998 110.756 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.761 ' HB3' HD21 ' A' ' 64' ' ' LEU . . . -127.49 -39.9 1.82 Allowed 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.545 -0.862 . . . . 1.5900000000000001 110.439 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 161.3 107.8 0.22 Allowed Glycine 0 N--CA 1.483 1.823 0 N-CA-C 109.614 -1.395 . . . . 0.75 109.614 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.433 ' HB1' HD23 ' A' ' 97' ' ' LEU . . . -163.86 115.46 1.37 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.24 -1.153 . . . . 0.93999999999999995 110.816 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 11.1 ttt180 -70.35 117.49 11.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.341 -0.849 . . . . 2.23 109.417 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.816 HD23 HG13 ' A' ' 82' ' ' VAL . 1.0 OUTLIER -105.49 9.56 33.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.336 -0.852 . . . . 1.23 110.908 -179.495 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -111.97 50.71 0.83 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.962 -1.086 . . . . 1.8899999999999999 110.431 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.771 HG11 ' HB2' ' A' ' 80' ' ' ARG . 1.2 p -108.39 -169.12 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.29 -0.881 . . . . 0.41999999999999998 109.865 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.614 ' H ' HG22 ' A' ' 106' ' ' VAL . 44.7 mtm180 -136.78 155.39 49.89 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.536 -0.728 . . . . 2.79 109.133 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.4 OUTLIER -86.12 50.56 2.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.12 -0.987 . . . . 1.6699999999999999 109.881 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.798 ' HB3' ' HE3' ' A' ' 110' ' ' TRP . . . 62.07 -60.84 0.11 Allowed 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 122.045 0.926 . . . . 1.2 110.663 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 1.102 ' CZ3' HG22 ' A' ' 77' ' ' THR . 2.1 m-90 -59.65 -34.93 73.45 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.706 -0.679 . . . . 2.4300000000000002 110.78 -178.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 133.21 -5.3 4.97 Favored Glycine 0 N--CA 1.484 1.881 0 C-N-CA 119.96 -1.114 . . . . 1.6599999999999999 110.929 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -79.19 158.31 27.69 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.964 -1.315 . . . . 3.54 111.005 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.517 HD23 ' HD2' ' A' ' 114' ' ' PRO . 0.3 OUTLIER -114.31 165.14 14.4 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.467 -0.771 . . . . 1.3999999999999999 110.131 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.517 ' HD2' HD23 ' A' ' 113' ' ' LEU . 41.5 Cg_endo -68.5 -28.78 31.74 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.699 1.368 . . . . 0.39000000000000001 109.246 178.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.5 HG12 ' HB3' ' A' ' 113' ' ' LEU . 10.7 p -79.25 -31.66 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.489 -0.757 . . . . 0.48999999999999999 109.31 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.93 -34.07 75.89 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.367 -0.833 . . . . 1.97 109.907 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.489 HD23 HD12 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -69.23 -45.49 69.69 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.425 -0.797 . . . . 1.3999999999999999 110.403 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.651 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -57.96 -47.4 83.05 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.372 -0.83 . . . . 0.66000000000000003 110.686 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.412 ' HG3' ' HB1' ' A' ' 127' ' ' ALA . 2.9 mt-10 -60.4 -30.05 69.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.343 -0.848 . . . . 2.3399999999999999 110.56 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -79.77 -38.89 32.14 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.253 -0.905 . . . . 2.4399999999999999 110.9 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.489 HD12 HD23 ' A' ' 117' ' ' LEU . 0.8 OUTLIER -80.34 -29.39 38.01 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.146 -0.971 . . . . 1.3300000000000001 110.426 -179.655 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 114.73 23.66 4.6 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 119.881 -1.152 . . . . 0.56000000000000005 110.543 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.496 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 81.4 m-70 -96.06 56.66 1.69 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.047 -1.266 . . . . 0.85999999999999999 109.038 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 23.3 mtp180 -46.96 -51.15 17.7 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.762 -0.586 . . . . 3.3999999999999999 110.451 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.505 ' HB3' HD12 ' A' ' 91' ' ' LEU . 50.1 m-20 -48.75 -39.68 25.8 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.553 -0.717 . . . . 1.9099999999999999 110.275 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.723 HG11 ' HA ' ' A' ' 86' ' ' ALA . 5.9 t -85.36 -41.11 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.291 -0.881 . . . . 0.46000000000000002 109.817 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.487 ' HB2' ' CB ' ' A' ' 118' ' ' ALA . . . -60.41 -35.99 77.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.199 -0.938 . . . . 0.46000000000000002 109.283 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 124' ' ' ARG . 10.0 ttt180 -66.45 -60.12 3.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.555 -0.716 . . . . 4.0700000000000003 109.363 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -57.96 -32.11 67.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.498 -0.751 . . . . 1.1399999999999999 109.663 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.808 HD11 ' HB2' ' A' ' 86' ' ' ALA . 17.6 mt -65.99 -48.53 70.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.436 -0.79 . . . . 1.3500000000000001 109.487 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -18.27 42.78 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.27 -0.893 . . . . 3.2799999999999998 110.104 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -86.49 -57.96 2.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.183 -0.948 . . . . 0.63 109.788 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -88.41 -52.08 5.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.512 -0.743 . . . . 0.80000000000000004 110.02 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.744 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . -62.48 -64.05 1.04 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.488 -0.757 . . . . 1.1699999999999999 110.394 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 137' ' ' THR . . . -106.59 53.57 0.62 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.451 -1.459 . . . . 2.2999999999999998 109.451 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.449 ' C ' HG23 ' A' ' 137' ' ' THR . . . -53.18 90.39 0.01 OUTLIER Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.568 -1.413 . . . . 3.6299999999999999 109.568 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.865 ' HB ' ' HA ' ' A' ' 147' ' ' ALA . 22.0 p -150.24 -179.75 7.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.48 -1.012 . . . . 3.8599999999999999 110.39 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 11.0 mtt85 -135.8 -103.17 0.21 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.238 -0.914 . . . . 9.3000000000000007 110.165 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 146' ' ' ASP . . . -168.34 -153.86 8.47 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.42 -1.472 . . . . 6.0700000000000003 109.42 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 7.8 t 41.93 -140.37 0.13 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.525 -0.985 . . . . 7.6900000000000004 112.064 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -137.84 160.01 40.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.331 -0.855 . . . . 9.5099999999999998 110.967 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.682 ' O ' ' CB ' ' A' ' 143' ' ' ALA . 0.1 OUTLIER 58.46 153.32 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.567 -0.708 . . . . 9.3800000000000008 112.538 178.45 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.682 ' CB ' ' O ' ' A' ' 142' ' ' HIS . . . 124.87 -121.18 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.077 0 N-CA-C 107.282 -1.377 . . . . 8.4600000000000009 107.282 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.696 ' O ' HG22 ' A' ' 145' ' ' ILE . 0.0 OUTLIER -84.82 10.53 11.28 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.463 -1.398 . . . . 8.5299999999999994 107.479 176.457 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.79 HD11 ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER 123.52 -13.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 C-N-CA 125.691 1.596 . . . . 11.85 107.405 -178.431 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.765 ' OD2' ' HB2' ' A' ' 152' ' ' SER . 0.0 OUTLIER 78.92 -35.82 0.17 Allowed 'General case' 0 N--CA 1.503 2.176 0 CA-C-N 114.475 -1.238 . . . . 12.800000000000001 113.554 177.873 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.865 ' HA ' ' HB ' ' A' ' 137' ' ' THR . . . -177.02 161.32 1.9 Allowed 'General case' 0 C--N 1.278 -2.519 0 O-C-N 121.238 -0.914 . . . . 14.640000000000001 113.036 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.619 ' O ' ' C ' ' A' ' 149' ' ' GLU . . . -8.85 76.73 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.512 0 N-CA-C 113.312 0.856 . . . . 16.5 113.312 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.79 ' HA ' HD11 ' A' ' 145' ' ' ILE . 35.8 mt-10 1.97 76.36 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.644 0 CA-C-O 121.321 0.582 . . . . 18.140000000000001 112.289 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.546 ' O ' ' O ' ' A' ' 154' ' ' ILE . . . -167.76 -68.11 0.03 OUTLIER Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.934 -1.127 . . . . 19.420000000000002 110.3 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.688 ' O ' ' OD2' ' A' ' 146' ' ' ASP . 55.7 Cg_endo -75.73 99.12 1.24 Allowed 'Trans proline' 0 C--N 1.296 -2.205 0 O-C-N 123.861 1.453 . . . . 21.210000000000001 110.961 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.765 ' HB2' ' OD2' ' A' ' 146' ' ' ASP . 14.1 t 171.71 -158.8 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.524 0 O-C-N 121.202 -0.936 . . . . 22.649999999999999 110.058 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.575 ' N ' ' OG ' ' A' ' 152' ' ' SER . 23.0 t0 -76.87 13.13 1.11 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 106.673 -1.603 . . . . 24.100000000000001 106.673 175.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.611 ' H ' ' C ' ' A' ' 152' ' ' SER . 0.3 OUTLIER -126.32 117.83 23.32 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 106.849 -1.538 . . . . 26.329999999999998 106.849 179.06 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.504 ' O ' ' HB3' ' A' ' 156' ' ' ASP . 53.0 Cg_endo -79.98 10.79 3.02 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 O-C-N 123.299 1.157 . . . . 28.57 113.578 -177.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.504 ' HB3' ' O ' ' A' ' 155' ' ' PRO . 1.2 p30 . . . . . 0 N--CA 1.509 2.482 0 CA-C-O 118.095 -0.955 . . . . 30.710000000000001 110.183 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.935 0 N-CA-C 109.979 -0.378 . . . . 18.49 109.979 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 54.8 tp10 -47.33 104.51 0.41 Allowed Pre-proline 0 N--CA 1.505 2.285 0 O-C-N 120.92 -1.113 . . . . 17.02 109.801 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.599 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 65.9 Cg_endo -92.56 -162.93 0.1 Allowed 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.817 1.43 . . . . 16.02 112.147 -177.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.62 ' O ' ' HB2' ' A' ' 5' ' ' ALA . . . 71.41 44.05 0.57 Allowed 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 115.683 -0.69 . . . . 13.31 111.193 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.62 ' HB2' ' O ' ' A' ' 4' ' ' ALA . . . 169.89 -54.9 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.202 0.525 . . . . 11.7 110.032 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -110.5 -12.17 17.73 Favored Glycine 0 N--CA 1.486 1.975 0 C-N-CA 119.88 -1.152 . . . . 10.07 110.25 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.518 ' O ' ' HB2' ' A' ' 8' ' ' SER . 9.6 t -72.37 -129.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.705 -1.468 . . . . 8.75 108.451 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.518 ' HB2' ' O ' ' A' ' 7' ' ' SER . 3.5 m 61.61 -90.72 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.102 -0.998 . . . . 7.24 111.919 178.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.474 ' C ' ' O ' ' A' ' 8' ' ' SER . 69.7 mtm 45.37 29.57 0.59 Allowed 'General case' 0 N--CA 1.506 2.359 0 N-CA-C 106.49 -1.67 . . . . 6.96 106.49 -176.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.442 ' N ' ' C ' ' A' ' 8' ' ' SER 0.25 2.6 tt0 -84.37 117.22 68.19 Favored Pre-proline 0 C--N 1.304 -1.374 0 CA-C-N 114.387 -1.279 . . . . 6.51 112.845 -175.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.952 ' O ' ' N ' ' A' ' 13' ' ' ALA . 52.1 Cg_endo -76.97 68.29 7.33 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 N-CA-C 104.273 -3.01 . . . . 5.37 104.273 174.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -34.64 11.48 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.566 0 N-CA-C 114.287 1.217 . . . . 4.37 114.287 -176.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.952 ' N ' ' O ' ' A' ' 11' ' ' PRO . . . -68.68 -32.24 71.92 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.724 -1.235 . . . . 1.44 109.322 178.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.537 ' O ' ' OG1' ' A' ' 18' ' ' THR . 0.7 OUTLIER -45.71 -37.82 6.25 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.34 -0.85 . . . . 2.47 109.623 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.702 ' HE3' HD21 ' A' ' 31' ' ' LEU . 35.4 m0 -62.26 -54.76 36.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.784 -0.572 . . . . 2.06 109.997 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.932 ' CD1' HD21 ' A' ' 63' ' ' LEU . 1.1 pp -51.12 -25.55 5.33 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.021 -1.049 . . . . 1.73 109.02 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.46 ' N ' ' HG ' ' A' ' 16' ' ' LEU . . . -87.48 -54.19 4.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.5 -0.75 . . . . 0.62 109.318 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.537 ' OG1' ' O ' ' A' ' 14' ' ' ASP . 0.2 OUTLIER -57.99 -48.05 81.17 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.208 -0.933 . . . . 1.01 109.092 178.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.525 ' HB1' ' HB3' ' A' ' 27' ' ' GLU . . . -57.51 -43.02 83.92 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.825 -0.806 . . . . 0.39 108.825 178.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.51 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -61.41 -49.08 78.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.527 -0.733 . . . . 0.31 109.075 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.724 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -57.57 -30.21 65.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.524 -0.735 . . . . 0.34 109.81 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.4 mtt180 -89.99 18.05 6.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.616 -0.678 . . . . 2.83 110.267 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 56.54 41.1 88.53 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.562 -1.415 . . . . 0.69 109.562 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.37 86.6 2.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.5 -1.0 . . . . 2.96 109.958 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.606 HG22 HG23 ' A' ' 59' ' ' VAL . 81.4 t -68.51 -52.68 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.376 -0.827 . . . . 0.58 110.131 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -50.45 -45.24 55.91 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.441 -0.787 . . . . 2.04 110.94 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.525 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -58.91 -53.3 59.92 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.307 -0.871 . . . . 1.95 110.321 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.639 HG12 ' CD2' ' A' ' 62' ' ' LEU . 46.3 t -65.88 -44.27 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.415 -0.803 . . . . 0.59 110.338 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.908 ' HA ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -47.5 -49.56 25.54 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.499 -0.751 . . . . 2.03 110.509 -179.744 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.36 -39.54 39.02 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.502 -0.749 . . . . 0.53 110.458 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.702 HD21 ' HE3' ' A' ' 15' ' ' TRP . 5.4 mt -54.82 -66.81 0.34 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.29 -0.881 . . . . 1.01 110.3 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.943 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 0.2 OUTLIER -53.07 -39.41 63.28 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.438 -0.789 . . . . 1.43 110.587 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 29' ' ' ARG . 1.7 mt-10 -68.9 -13.25 62.32 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.054 -1.029 . . . . 1.65 109.522 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -98.82 -16.71 18.78 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.317 -0.865 . . . . 0.96 110.729 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 141.58 8.13 0.72 Allowed Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.512 -1.328 . . . . 0.74 111.748 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.943 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -57.92 129.57 42.54 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.6 -1.53 . . . . 0.73 109.983 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.696 ' CB ' ' HB2' ' A' ' 13' ' ' ALA . 3.2 tp -64.14 132.21 95.23 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.39 -0.819 . . . . 1.63 110.48 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.22 -37.16 3.55 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.536 1.282 . . . . 1.09 110.498 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -117.86 70.78 0.8 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.321 -0.862 . . . . 1.49 110.356 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.67 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -101.9 140.09 20.89 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.36 -0.837 . . . . 0.79 110.591 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -76.39 121.08 5.87 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.726 1.382 . . . . 1.63 110.468 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -97.03 177.42 5.61 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.291 -0.88 . . . . 2.52 110.02 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.3 m -86.09 -5.05 59.28 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.249 -0.907 . . . . 2.12 110.695 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -98.44 9.54 42.91 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.159 -0.963 . . . . 2.43 110.607 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.59 22.52 32.46 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.298 -1.521 . . . . 0.69 109.298 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.6 mtt180 -115.04 153.68 30.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.442 -1.034 . . . . 2.13 110.266 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.628 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 4.2 mmp_? -68.07 172.69 3.92 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.432 -0.793 . . . . 2.29 109.594 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.628 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 46.2 Cg_endo -72.29 -11.47 26.81 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 O-C-N 123.466 1.245 . . . . 1.64 111.868 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.496 ' O ' ' HG2' ' A' ' 52' ' ' MET . 7.8 mt -109.02 -37.67 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.892 -1.13 . . . . 0.66 109.371 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -53.18 -21.78 5.6 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.139 -0.976 . . . . 1.8 109.412 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.724 HG22 ' HB2' ' A' ' 21' ' ' ALA . 11.9 p -113.18 39.66 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.476 -0.765 . . . . 0.67 109.844 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.584 ' HE1' ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -103.4 33.78 3.2 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.99 -1.069 . . . . 1.4 110.191 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.437 ' CB ' ' O ' ' A' ' 52' ' ' MET . 4.8 tmm? 69.07 -17.71 0.2 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.63 -0.669 . . . . 1.5 111.35 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.474 ' SD ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 52.31 24.23 2.79 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.918 -1.113 . . . . 1.0 110.17 -179.624 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.421 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -120.42 9.08 10.97 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.281 -1.528 . . . . 0.54 109.281 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -153.16 93.31 1.71 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.349 -1.089 . . . . 0.65 109.921 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.35 -25.73 50.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.364 -0.835 . . . . 0.39 109.86 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 35.3 mtt180 -54.2 -43.66 70.95 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.374 -0.829 . . . . 2.46 109.638 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.606 HG23 HG22 ' A' ' 25' ' ' VAL . 61.1 t -56.11 -53.4 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.365 -0.835 . . . . 0.54 108.976 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.584 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -53.91 -40.28 66.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.424 -0.797 . . . . 0.53 109.828 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.83 -68.81 0.14 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.092 -1.005 . . . . 2.02 110.068 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.934 HD21 ' HB2' ' A' ' 32' ' ' LEU . 0.7 OUTLIER -47.35 -58.73 3.81 Favored 'General case' 0 C--N 1.313 -0.978 0 O-C-N 121.282 -0.886 . . . . 1.6 109.778 178.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.932 HD21 ' CD1' ' A' ' 16' ' ' LEU . 2.3 mt -53.47 -65.76 0.51 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.675 -0.64 . . . . 1.1 110.713 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.956 HD13 HG12 ' A' ' 96' ' ' VAL . 2.8 tt -48.58 -54.79 13.15 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.612 -0.68 . . . . 1.49 110.634 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.671 ' O ' HD12 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -59.5 -24.26 63.48 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.236 -0.915 . . . . 1.14 109.887 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.778 ' CG ' HD22 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -87.11 -27.83 22.86 Favored 'General case' 0 C--N 1.31 -1.142 0 O-C-N 121.273 -0.892 . . . . 1.27 110.122 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 132.6 36.65 0.28 Allowed Glycine 0 N--CA 1.481 1.685 0 C-N-CA 119.925 -1.131 . . . . 0.67 111.11 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.477 ' HB1' HG13 ' A' ' 49' ' ' ILE . . . -63.62 -161.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.744 -1.445 . . . . 0.52 109.555 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.516 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -120.32 62.7 9.16 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.229 -0.92 . . . . 2.73 109.825 179.616 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.473 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 43.6 Cg_endo -69.2 -14.39 37.76 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.825 1.434 . . . . 0.65 110.411 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.403 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 20.9 t30 -104.81 -63.15 1.25 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.362 -0.836 . . . . 1.95 110.397 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -49.49 152.17 1.41 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.367 -0.833 . . . . 0.95 110.828 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -136.37 -163.38 1.4 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.434 -0.791 . . . . 0.57 109.883 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.405 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -92.1 133.7 29.85 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.242 -0.911 . . . . 1.58 109.679 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.63 -7.44 21.2 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.33 1.174 . . . . 0.8 110.708 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.62 -56.87 3.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.156 -0.965 . . . . 0.98 109.861 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 1.102 HG22 ' CZ3' ' A' ' 110' ' ' TRP . 19.0 p -120.23 15.71 12.28 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.301 -0.874 . . . . 1.17 110.28 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.483 ' HB3' ' O ' ' A' ' 107' ' ' ARG . 4.2 mt 49.32 28.64 2.38 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.362 -0.836 . . . . 0.56 110.995 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 m -65.13 102.37 0.63 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 0.75 110.676 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.771 ' HB2' HG11 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -79.77 157.59 74.09 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.254 -0.904 . . . . 1.78 108.756 178.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.584 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 39.2 Cg_endo -66.03 -12.86 37.23 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.219 1.115 . . . . 0.45 110.325 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.816 HG13 HD23 ' A' ' 104' ' ' LEU . 78.5 t -63.91 -34.19 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.354 -0.841 . . . . 0.37 109.692 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.423 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 14.9 m80 -69.11 -47.03 66.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.391 -0.818 . . . . 0.31 109.321 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.474 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 1.0 OUTLIER -48.27 -43.85 33.07 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.902 -0.498 . . . . 1.43 111.256 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.742 ' HB1' HD12 ' A' ' 94' ' ' LEU . . . -62.33 -61.0 2.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.084 -1.01 . . . . 0.27 109.499 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.808 ' HB2' HD11 ' A' ' 130' ' ' LEU . . . -60.21 -32.98 71.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.379 -0.825 . . . . 0.4 110.845 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.438 ' HG2' HD22 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -52.9 -44.16 66.72 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.014 -1.054 . . . . 2.77 110.415 -179.727 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.442 ' HB2' ' HB3' ' A' ' 54' ' ' MET . 0.4 OUTLIER -91.5 -5.02 54.86 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.37 -0.831 . . . . 2.01 110.204 179.764 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.61 33.77 26.96 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.43 -1.468 . . . . 0.44 109.43 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.421 ' CE2' ' C ' ' A' ' 55' ' ' GLY . 0.3 OUTLIER -102.69 99.43 9.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.264 -1.139 . . . . 0.75 110.949 -179.558 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.505 HD12 ' HB3' ' A' ' 125' ' ' ASP . 0.4 OUTLIER -75.57 -34.59 60.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.914 . . . . 1.18 109.841 179.348 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -51.09 -38.94 54.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.437 -0.79 . . . . 1.71 109.941 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.578 ' O ' HD12 ' A' ' 97' ' ' LEU . 52.9 m -66.67 -43.45 84.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.553 -0.717 . . . . 0.44 109.559 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.742 HD12 ' HB1' ' A' ' 85' ' ' ALA . 1.8 mp -55.62 -43.12 75.82 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.427 -0.796 . . . . 1.03 109.789 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 99' ' ' ARG . 60.0 t -57.36 -53.07 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.489 -0.757 . . . . 0.51 109.809 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.956 HG12 HD13 ' A' ' 64' ' ' LEU . 52.2 t -53.33 -45.79 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.32 -0.862 . . . . 0.39 110.018 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.795 ' HA ' HD11 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -56.62 -53.29 59.31 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.451 -0.781 . . . . 1.14 110.531 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -80.09 -12.44 59.68 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.292 -0.88 . . . . 0.78 110.779 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' A' ' 95' ' ' VAL . 14.2 ttt85 -79.13 -16.91 55.98 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.232 -0.918 . . . . 2.8 110.756 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.761 ' HB3' HD21 ' A' ' 64' ' ' LEU . . . -127.49 -39.9 1.82 Allowed 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.545 -0.862 . . . . 1.59 110.439 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 161.3 107.8 0.22 Allowed Glycine 0 N--CA 1.483 1.823 0 N-CA-C 109.614 -1.395 . . . . 0.75 109.614 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.433 ' HB1' HD23 ' A' ' 97' ' ' LEU . . . -163.86 115.46 1.37 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.24 -1.153 . . . . 0.94 110.816 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 11.1 ttt180 -70.35 117.49 11.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.341 -0.849 . . . . 2.23 109.417 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.816 HD23 HG13 ' A' ' 82' ' ' VAL . 1.0 OUTLIER -105.49 9.56 33.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.336 -0.852 . . . . 1.23 110.908 -179.495 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -111.97 50.71 0.83 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.962 -1.086 . . . . 1.89 110.431 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.771 HG11 ' HB2' ' A' ' 80' ' ' ARG . 1.2 p -108.39 -169.12 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.29 -0.881 . . . . 0.42 109.865 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.614 ' H ' HG22 ' A' ' 106' ' ' VAL . 44.7 mtm180 -136.78 155.39 49.89 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.536 -0.728 . . . . 2.79 109.133 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.4 OUTLIER -86.12 50.56 2.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.12 -0.987 . . . . 1.67 109.881 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.798 ' HB3' ' HE3' ' A' ' 110' ' ' TRP . . . 62.07 -60.84 0.11 Allowed 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 122.045 0.926 . . . . 1.2 110.663 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 1.102 ' CZ3' HG22 ' A' ' 77' ' ' THR . 2.1 m-90 -59.65 -34.93 73.45 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.706 -0.679 . . . . 2.43 110.78 -178.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 133.21 -5.3 4.97 Favored Glycine 0 N--CA 1.484 1.881 0 C-N-CA 119.96 -1.114 . . . . 1.66 110.929 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -79.19 158.31 27.69 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.964 -1.315 . . . . 3.54 111.005 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.517 HD23 ' HD2' ' A' ' 114' ' ' PRO . 0.3 OUTLIER -114.31 165.14 14.4 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.467 -0.771 . . . . 1.4 110.131 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.517 ' HD2' HD23 ' A' ' 113' ' ' LEU . 41.5 Cg_endo -68.5 -28.78 31.74 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.699 1.368 . . . . 0.39 109.246 178.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.5 HG12 ' HB3' ' A' ' 113' ' ' LEU . 10.7 p -79.25 -31.66 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.489 -0.757 . . . . 0.49 109.31 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.93 -34.07 75.89 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.367 -0.833 . . . . 1.97 109.907 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.489 HD23 HD12 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -69.23 -45.49 69.69 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.425 -0.797 . . . . 1.4 110.403 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.651 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -57.96 -47.4 83.05 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.372 -0.83 . . . . 0.66 110.686 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.412 ' HG3' ' HB1' ' A' ' 127' ' ' ALA . 2.9 mt-10 -60.4 -30.05 69.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.343 -0.848 . . . . 2.34 110.56 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -79.77 -38.89 32.14 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.253 -0.905 . . . . 2.44 110.9 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.489 HD12 HD23 ' A' ' 117' ' ' LEU . 0.8 OUTLIER -80.34 -29.39 38.01 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.146 -0.971 . . . . 1.33 110.426 -179.655 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 114.73 23.66 4.6 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 119.881 -1.152 . . . . 0.56 110.543 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.496 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 81.4 m-70 -96.06 56.66 1.69 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.047 -1.266 . . . . 0.86 109.038 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 23.3 mtp180 -46.96 -51.15 17.7 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.762 -0.586 . . . . 3.4 110.451 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.505 ' HB3' HD12 ' A' ' 91' ' ' LEU . 50.1 m-20 -48.75 -39.68 25.8 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.553 -0.717 . . . . 1.91 110.275 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.723 HG11 ' HA ' ' A' ' 86' ' ' ALA . 5.9 t -85.36 -41.11 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.291 -0.881 . . . . 0.46 109.817 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.487 ' HB2' ' CB ' ' A' ' 118' ' ' ALA . . . -60.41 -35.99 77.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.199 -0.938 . . . . 0.46 109.283 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 124' ' ' ARG . 10.0 ttt180 -66.45 -60.12 3.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.555 -0.716 . . . . 4.07 109.363 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -57.96 -32.11 67.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.498 -0.751 . . . . 1.14 109.663 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.808 HD11 ' HB2' ' A' ' 86' ' ' ALA . 17.6 mt -65.99 -48.53 70.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.436 -0.79 . . . . 1.35 109.487 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -18.27 42.78 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.27 -0.893 . . . . 3.28 110.104 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -86.49 -57.96 2.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.183 -0.948 . . . . 0.63 109.788 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -88.41 -52.08 5.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.512 -0.743 . . . . 0.8 110.02 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.744 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . -62.48 -64.05 1.04 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.488 -0.757 . . . . 1.17 110.394 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 137' ' ' THR . . . -106.59 53.57 0.62 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.451 -1.459 . . . . 2.3 109.451 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.449 ' C ' HG23 ' A' ' 137' ' ' THR . . . -53.18 90.39 0.01 OUTLIER Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.568 -1.413 . . . . 3.63 109.568 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.865 ' HB ' ' HA ' ' A' ' 147' ' ' ALA . 22.0 p -150.24 -179.75 7.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.48 -1.012 . . . . 3.86 110.39 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 11.0 mtt85 -135.8 -103.17 0.21 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.238 -0.914 . . . . 9.3 110.165 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 146' ' ' ASP . . . -168.34 -153.86 8.47 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.42 -1.472 . . . . 6.07 109.42 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 7.8 t 41.93 -140.37 0.13 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.525 -0.985 . . . . 7.69 112.064 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -137.84 160.01 40.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.331 -0.855 . . . . 9.51 110.967 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.682 ' O ' ' CB ' ' A' ' 143' ' ' ALA . 0.1 OUTLIER 58.46 153.32 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.567 -0.708 . . . . 9.38 112.538 178.45 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.682 ' CB ' ' O ' ' A' ' 142' ' ' HIS . . . 124.87 -121.18 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.077 0 N-CA-C 107.282 -1.377 . . . . 8.46 107.282 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.696 ' O ' HG22 ' A' ' 145' ' ' ILE . 0.0 OUTLIER -84.82 10.53 11.28 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.463 -1.398 . . . . 8.53 107.479 176.457 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.79 HD11 ' HA ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER 123.52 -13.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 C-N-CA 125.691 1.596 . . . . 11.85 107.405 -178.431 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.765 ' OD2' ' HB2' ' A' ' 152' ' ' SER . 0.0 OUTLIER 78.92 -35.82 0.17 Allowed 'General case' 0 N--CA 1.503 2.176 0 CA-C-N 114.475 -1.238 . . . . 12.8 113.554 177.873 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.865 ' HA ' ' HB ' ' A' ' 137' ' ' THR . . . -177.02 161.32 1.9 Allowed 'General case' 0 C--N 1.278 -2.519 0 O-C-N 121.238 -0.914 . . . . 14.64 113.036 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.619 ' O ' ' C ' ' A' ' 149' ' ' GLU . . . -8.85 76.73 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.512 0 N-CA-C 113.312 0.856 . . . . 16.5 113.312 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.79 ' HA ' HD11 ' A' ' 145' ' ' ILE . 35.8 mt-10 1.97 76.36 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.644 0 CA-C-O 121.321 0.582 . . . . 18.14 112.289 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.546 ' O ' ' O ' ' A' ' 154' ' ' ILE . . . -167.76 -68.11 0.03 OUTLIER Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.934 -1.127 . . . . 19.42 110.3 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.688 ' O ' ' OD2' ' A' ' 146' ' ' ASP . 55.7 Cg_endo -75.73 99.12 1.24 Allowed 'Trans proline' 0 C--N 1.296 -2.205 0 O-C-N 123.861 1.453 . . . . 21.21 110.961 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.765 ' HB2' ' OD2' ' A' ' 146' ' ' ASP . 14.1 t 171.71 -158.8 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.524 0 O-C-N 121.202 -0.936 . . . . 22.65 110.058 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.575 ' N ' ' OG ' ' A' ' 152' ' ' SER . 23.0 t0 -76.87 13.13 1.11 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 106.673 -1.603 . . . . 24.1 106.673 175.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.611 ' H ' ' C ' ' A' ' 152' ' ' SER . 0.3 OUTLIER -126.32 117.83 23.32 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 106.849 -1.538 . . . . 26.33 106.849 179.06 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.504 ' O ' ' HB3' ' A' ' 156' ' ' ASP . 53.0 Cg_endo -79.98 10.79 3.02 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 O-C-N 123.299 1.157 . . . . 28.57 113.578 -177.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.504 ' HB3' ' O ' ' A' ' 155' ' ' PRO . 1.2 p30 . . . . . 0 N--CA 1.509 2.482 0 CA-C-O 118.095 -0.955 . . . . 30.71 110.183 178.797 . . . . . . . . 1 1 . 1 stop_ save_